Why wasn't the FDA communications made public. That's the problem with this company. Can't selectively put out only positive or just pump worthy news. This shouldn't have come from Liau in her own presentation (not related to NWBO).
Maybe but seems like a real risk for fledgeling MHRA to go that route rather than FDA or EMA?? And, I’m almost certain she intentionally waited for EMA to cut the umbilical cord before submitting to MHRA, for whatever reason.
Then why wouldn’t they submit to EMA which is a much larger market and then submit to MHRA via IRP and have it approved in 110 days or less?
Not sure what location has to do with anything. They aren’t submitting via double decker bus. There were trial locations in Germany and Fraunhofer is there.